Does rose angina predict 23-year coronary heart disease mortality in women and men aged 40-49 years?
Angina symptoms in ages as low as 40-49 years were associated with elevated long-term CHD mortality in Norwegian women and men. This indicates that the three-item version of the Rose Angina Questionnaire, although a screening tool rather than a diagnostic test, adds information on undiagnosed CHD in both sexes.
Within this racially integrated sample of hypertensive adults who share similar health care markets, race differences in treatment and control of hypertension were eliminated. Accounting for the social context should be considered in public health interventions to increase hypertension awareness and management.